Three Things About Gleason Grading That Just About Everyone Believes But That Are Almost Certainly Wrong - 28/08/20
Doi : 10.1016/j.urology.2020.03.042
Andrew J. Vickers a, ⁎ 
, Samson W. Fine b
, Samson W. Fine b a Departments of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY
b Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY
⁎Address correspondence to: Andrew Vickers, Ph.D., Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 485 Lexington Ave, New York, NY 10017Department of Epidemiology and BiostatisticsMemorial Sloan Kettering Cancer Center485 Lexington AveNew YorkNY10017
Le texte complet de cet article est disponible en PDF.
Plan
| Conflicts of Interest: Andrew Vickers is named on a patent for a statistical method to detect prostate cancer that has been commercialized by OPKO Health. Andrew Vickers receives royalties from sales of the test and has stock options in OPKO Health. |
|
| Funding: This work was supported in part by the National Institutes of Health/National Cancer Institute (NIH/NCI) with a Cancer Center Support Grant to Memorial Sloan Kettering Cancer Center [P30 CA008748], a SPORE grant in Prostate Cancer to Dr H. Scher [P50-CA92629], the Sidney Kimmel Center for Prostate and Urologic Cancers and David H. Koch through the Prostate Cancer Foundation. |
© 2020
Elsevier Inc. Tous droits réservés.
Vol 143
P. 16-19 - septembre 2020 Retour au numéro
Article précédent
- Surgical Precautions for Urologists in the Era of COVID-19
- Ming-Chun Chan, Jia-Lun Kwok, Sharon E.K. Yeo, Yew-Lam Chong
- 3D Printing, Augmented Reality, and Virtual Reality for the Assessment and Management of Kidney and Prostate Cancer: A Systematic Review
- Nicole Wake, Jeffrey E. Nussbaum, Marie I. Elias, Christine V. Nikas, Marc A. Bjurlin
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?